Bausch Health investigated by US Department of Justice over misleading marketing

Three plaque psoriasis drugs and one fungal treatment are the suspects in a case concerning wrongful marketing by Canadian pharmaceutical firm Bausch Health, and the US Department of Justice is reportedly looking into the matter.
by christian bundgaard, translated by daniel pedersen

Bausch Health has run into problems with the US authorities, as the Canadian company is being investigated for having marketed three plaque psoriasis treatments and one fungal treatment for unintended use, media Endpoints News reports based on a Stat News story.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading